Tolerability of ketorolac administered via continuous subcutaneous infusion for cancer pain: a preliminary report.

@article{Conno1994TolerabilityOK,
  title={Tolerability of ketorolac administered via continuous subcutaneous infusion for cancer pain: a preliminary report.},
  author={Franco de Conno and Ernesto Zecca and Cinzia Martini and Carla Ida Ripamonti and Augusto T Caraceni and Luigi Saita},
  journal={Journal of pain and symptom management},
  year={1994},
  volume={9 2},
  pages={119-21}
}
We evaluated the local and systemic tolerability of ketorolac administered through continuous subcutaneous infusion in ten cancer patients. The patients were monitored daily for the severity and duration of pain, and the development of other symptoms. The duration of injection site varied from 1 to more than 7 days. No patients complained of local… CONTINUE READING